GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serum

PCR is, to date, the only available tool for the detection of GB virus C (GBV-C) and hepatitis G virus (HGV) RNAs. Twenty-two French laboratories participated in a quality control study to assess the sensitivity and specificity of their procedures. The panel included 13 positive controls and 7 negat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical microbiology 1997-12, Vol.35 (12), p.3298-3300
Hauptverfasser: Bogard, Marc, Buffet-Janvresse, Claudine, Cantaloube, Jean-François, Biagini, Philippe, Duverlie, Gilles, Castelain, Sandrine, Izopet, Jacques, Dubois, Martine, Defer, Christine, Lepot, Isabelle, Coste, Joliette, Marcellin, Patrick, Martinot-Peignoux, Michèle, Halfon, Philippe, Gerolami, Victoria, Frangeul, L., Pawlotsky, Jean-Michel, Roudot-Thoraval, Françoise, Dussaix, Elisabeth, Loiseau, Pascale, Ravera, Nadine, Lewin, Patricia, Lamoril, Jérôme, Lerable, Joëlle, Bouchardeau, Françoise, Laperche, Syria, Mariotti, Martine, Lefrère, Jean-Jacques, Nicot, Thierry, Denis, Francois, Gassain, Michèle, Mérel, Patrick, Trépo, Christian, Thiers, Valerie, Bréchot, Christian, Férec, Claude, Stoll-Keller, Françoise, Palmer, Pierre, Lebon, Pierre
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PCR is, to date, the only available tool for the detection of GB virus C (GBV-C) and hepatitis G virus (HGV) RNAs. Twenty-two French laboratories participated in a quality control study to assess the sensitivity and specificity of their procedures. The panel included 13 positive controls and 7 negative controls. The laboratories used either in-house PCR techniques adapted from the literature or partly standardized commercial tests. Three laboratories performed faultlessly with the entire panel. Most laboratories had excellent specificity (100% in 20 of 22 laboratories). Sensitivity was acceptable (85 to 100%) in 15 centers and insufficient (38 to 77%) in 7. As with nonstandardized in-house PCR, the commercial assays gave discrepant performances in different laboratories. These results suggest that laboratories willing to use PCR for detection of GBV-C/HGV RNA for research or diagnostic purposes should participate in multicenter quality control trials.
ISSN:0095-1137
DOI:10.1128/jcm.35.12.3298-3300.1997